I downgrade National Vision Holdings to a hold rating due to lack of near-term stock price appreciation and the need for tangible growth evidence. 3Q24 earnings showed modest growth, with net revenue up 2.9% y/y, driven by higher tickets and slight same-store sales growth. Strategic initiatives like new product launches and store fleet optimization are positive but require time to show significant impact on growth and productivity.
EYE's third-quarter 2024 results reflect ongoing strength in Managed Care, with growth in America's Best stores.
National Vision Holdings, Inc. (NASDAQ:EYE ) Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants Tamara Gonzalez - Vice President, Investor Relations Reade Fahs - Chief Executive Officer Alex Wilkes - President Melissa Rasmussen - Chief Financial Officer Conference Call Participants Michael Lasser - UBS Kate McShane - Goldman Sachs Zachary Fadem - Wells Fargo Jon Elias - BMO Capital Markets Dylan Carden - William Blair Paul Lejuez - Citi Brian Tanquilut - Jefferies Adrienne Yih - Barclays Molly Baum - Bank of America Operator Good day, and thank you for standing by. Welcome to the National Vision Third Quarter 2024 Earnings Conference Call.
National Vision (EYE) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.15 per share a year ago.
National Vision (EYE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
National Vision's America's Best stores become the exclusive retail partner of Pair Eyewear.
The strong execution of strategic initiatives and robust market expansion of the Owned and Host segment bode well for National Vision.
National Vision (EYE) delivers an earnings beat in the second quarter of 2024 and announces new transformative actions for long-term growth.
National Vision Holdings Inc (NASDAQ:EYE ) Q2 2024 Results Conference Call August 6, 2024 4:30 PM ET Company Participants Tamara Gonzalez - IR Reade Fahs - CEO, President & Director Melissa Rasmussen - Senior VP & CFO Conference Call Participants Michael Lasser - UBS Simeon Siegel - BMO Capital Markets Anthony Chukumba - Loop Capital Markets Kate McShane - Goldman Sachs Zach Fadem - Wells Fargo Simeon Gutman - Morgan Stanley Brian Tanquilut - Jefferies Brandon Cheatham - Citigroup Adrienne Yih - Barclays Dylan Carden - William Blair Operator Good day, and thank you for standing by. Welcome to the Q2 2024 National Vision Holdings Earnings Conference Call.
National Vision (EYE) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.17 per share a year ago.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Investors looking for stocks in the Medical - Products sector might want to consider either National Vision (EYE) or Insulet (PODD). But which of these two stocks presents investors with the better value opportunity right now?